AdventHealth Translational Research Institute
Orlando, Florida, 32803, United States
NCT Number: NCT04722354
The purpose of this study is to determine the effects of oral abscisic acid (ABA) on glucose metabolism in subjects with defined prediabetes.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
Orlando, Florida, 32803, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Following a 12-hour overnight fast at the CRU (including abstinence from caffeine containing foods and beverages), insulin sensitivity will be measured using the criterion method of the euglycemic clamp. Participants will have not performed vigorous physical activity for at least the previous 24 h, and be free of acute illness for the prior 2 weeks. An intravenous catheter will be placed in an antecubital vein for subsequent insulin (40 mU/m2-min) and glucose infusions and for stable isotope (6, 6-2H2) infusions to measure insulin sensitivity.
One biopsy taken prior to clamp and a second biopsy taken 30-45 min after the start of the clamp. A biopsy of the Vastus Lateralis muscle will be performed on the leg/thigh using the Bergstrom technique.
Those in this group will receive ABA (95 µg ABA and 300 mg of corn starch)
Those in this group will receive placebo (300 mg cornstarch)
Time frame: 10 weeks
Adverse events will be monitored at each visit throughout the duration of the study.
Time frame: After 2 weeks of treatment
Rate of glucose disposal, measured by hyperinsulinic euglycemic clamp, normalized to pre-treatment baseline (mg/min)
AdventHealth Translational Research Institute
Other
Acronym: ABA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00063674
Adherence Interventions, Behavior
Palo Alto, California, United States
View Trial DetailsNCT03919877
Diabetes Mellitus, Diabetes Mellitus, Type 2
Stanford, California, United States
View Trial DetailsNCT07061496
Behavior, Glucose Intolerance
Nowshera, Pakistan
View Trial DetailsNCT04773834
Glucose Intolerance, Glucose Metabolism Disorders
New York, United States
View Trial Details